Literature DB >> 165154

Characteristics of cell lines derived from human leukocytes transformed by different strains of Epstein-Barr virus.

T Katsuki, Y Hinuma.   

Abstract

Variation of Epstein-Barr virus (EBV) in respect to its effect on the properties of transformed cells was probed. Human umbilical cord leukocytes from six different individuals were transformed in vitro by either B95-8 (B) or QIMR-WIL (Q) strains of EBV and subsequently 12 lymphoblastoid cell lines (six B-derived and six Q-derived lines) were established. The B lines and Q lines were different in the expression of EBV genome i.e. production of virus or viral antigens, and in other properties including growth pattern and immunoglobulin production. The most striking differences between the two groups lay in their capacity to produce infectious virus and in the shape of the cell-clumps. The results suggest that different strains of EBV may induce transformed cells with different characteristics.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 165154     DOI: 10.1002/ijc.2910150205

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  8 in total

1.  Adenosine deaminase (ADA) deficiency due to deletion of the ADA gene promoter and first exon by homologous recombination between two Alu elements.

Authors:  M L Markert; J J Hutton; D A Wiginton; J C States; R E Kaufman
Journal:  J Clin Invest       Date:  1988-05       Impact factor: 14.808

2.  Biological properties and viral surface antigens of Burkitt lymphoma- and mononucleosis- derived strains of Epstein-Barr virus released from transformed marmoset cells.

Authors:  G Miller; D Coope; J Niederman; J Pagano
Journal:  J Virol       Date:  1976-06       Impact factor: 5.103

3.  Characteristics of hematopoietic cell line established from human myelomonocytic leukemia.

Authors:  T Kimoto; M Namba; A Ueki; F Hyodoh
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1976-08-19

4.  Molecular analysis of mutations in a patient with purine nucleoside phosphorylase deficiency.

Authors:  M R Aust; L G Andrews; M J Barrett; C J Norby-Slycord; M L Markert
Journal:  Am J Hum Genet       Date:  1992-10       Impact factor: 11.025

5.  A high proportion of ADA point mutations associated with a specific alanine-to-valine substitution.

Authors:  M L Markert; C Norby-Slycord; F E Ward
Journal:  Am J Hum Genet       Date:  1989-09       Impact factor: 11.025

6.  Cytolytic CD4(+)-T-cell clones reactive to EBNA1 inhibit Epstein-Barr virus-induced B-cell proliferation.

Authors:  Sarah Nikiforow; Kim Bottomly; George Miller; Christian Münz
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

7.  Amplification of HTLV-1-related sequences among patients with neurological disorders in highly endemic Nagasaki: lack of evidence for association of HTLV-1 with multiple sclerosis.

Authors:  D Nakayama; S Katamine; H Kanazawa; N Shibuya; K Kawase; R Moriuchi; T Miyamoto; S Hino
Journal:  Jpn J Cancer Res       Date:  1990-03

8.  Maternal transmission of HTLV-1 other than through breast milk: discrepancy between the polymerase chain reaction positivity of cord blood samples for HTLV-1 and the subsequent seropositivity of individuals.

Authors:  K Kawase; S Katamine; R Moriuchi; T Miyamoto; K Kubota; H Igarashi; H Doi; Y Tsuji; T Yamabe; S Hino
Journal:  Jpn J Cancer Res       Date:  1992-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.